ROIVANT SCIENCES LTD's ticker is and the CUSIP is G76279101. A total of 226 filers reported holding ROIVANT SCIENCES LTD in Q4 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,058 | -13.9% | 383,912 | -14.1% | 0.00% | -50.0% |
| Q1 2024 | $4,711 | +6.3% | 446,962 | +13.3% | 0.00% | 0.0% |
| Q4 2023 | $4,430 | +2.5% | 394,370 | +6.6% | 0.00% | -33.3% |
| Q3 2023 | $4,321 | +9.8% | 370,050 | -5.2% | 0.00% | +50.0% |
| Q2 2023 | $3,934 | +129.9% | 390,231 | +68.3% | 0.00% | +100.0% |
| Q1 2023 | $1,711 | +68.1% | 231,868 | +81.9% | 0.00% | – |
| Q4 2022 | $1,018 | -89.8% | 127,436 | +3984.5% | 0.00% | – |
| Q3 2022 | $10,000 | -86.5% | 3,120 | -82.8% | 0.00% | – |
| Q2 2022 | $74,000 | +42.3% | 18,115 | +71.2% | 0.00% | – |
| Q1 2022 | $52,000 | – | 10,580 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 66,719,779 | $705,228,064 | 66.32% |
| Patient Square Capital LP | 12,228,465 | $129,254,875 | 59.99% |
| Atalaya Capital Management LP | 1,714,843 | $18,125,891 | 40.31% |
| Two Seas Capital LP | 10,318,764 | $109,069,335 | 17.73% |
| Anchorage Capital Group, L.L.C. | 4,832,642 | $51,081,026 | 15.77% |
| Whitefort Capital Management, LP | 2,391,000 | $25,272,870 | 15.58% |
| STEMPOINT CAPITAL LP | 2,712,741 | $28,673,672 | 8.43% |
| Tejara Capital Ltd | 2,183,943 | $23,084,278 | 8.39% |
| Tyro Capital Management LLC | 1,744,327 | $18,437,536 | 8.36% |
| ADAR1 Capital Management, LLC | 4,150,009 | $43,865,595 | 8.28% |